Keratan sulfate exacerbates experimental autoimmune encephalomyelitis

Area of Science:

• Neuroimmunology
• Glycosaminoglycan Biology
• Extracellular Matrix Research

Background:

• Proteoglycans (PGs) are key components of the central nervous system (CNS) extracellular matrix.
• Keratan sulfate (KS), a glycosaminoglycan within KS-PGs, inhibits nerve regeneration post-CNS injury.
• The role of KS in immune-mediated CNS diseases remains largely unexplored.

Purpose of the Study:

• To investigate the involvement of KS in immune diseases, specifically experimental autoimmune encephalomyelitis (EAE).
• To elucidate the function of N-acetylglucosamine (GlcNAc)-6-O-sulfotransferase 1 (GlcNAc6ST1) in the pathogenesis of EAE.

Main Methods:

• Induction of EAE in wild-type and KS-deficient (KS-KO) mice lacking the GlcNAc6ST1 gene.
• Assessment of EAE severity and immune cell responses in KS-KO mice compared to controls.

Main Results:

• KS-KO mice exhibited significantly reduced severity of EAE.
• A repressed recall immune response was observed during the induction phase of EAE in KS-KO mice.
• GlcNAc6ST1 may influence pathogenic lymphocyte trafficking across the blood-brain barrier via adhesion molecules.

Conclusions:

• KS plays a role in the pathogenesis of neuroinflammatory diseases like EAE.
• Modulating KS synthesis or function presents a potential therapeutic strategy for neuroimmunological disorders.
• Targeting GlcNAc6ST1 could offer a novel approach to treating conditions involving the CNS immune system.